Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
JAMA Network Open|October 6, 2022
Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood FactorsIhab Hajjar, Zhiyi Yang, Maureen Okafor, et al.
Journal of Alzheimer'S Disease : JAD|March 15, 2014
Qualification of a surrogate matrix-based absolute quantification method for amyloid-β₄₂ in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometryMagdalena Korecka, Teresa Waligorska, Michal Figurski, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 4, 2021
Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson DiseaseWhitley W Aamodt, Teresa Waligorska, Junchao Shen, et al.
Neurology|September 11, 2020
Effect of escitalopram dose and treatment duration on CSF Aβ levels in healthy older adults: A controlled clinical trialYvette I Sheline, B Joy Snider, Joanne C Beer, et al.
British Journal of Anaesthesia|September 18, 2021
Perioperative neurocognitive and functional neuroimaging trajectories in older APOE4 carriers compared with non-carriers: secondary analysis of a prospective cohort studyJeffrey N Browndyke, Mary C Wright, Rosa Yang, et al.
Annals of Clinical and Translational Neurology|December 15, 2022
Plasma phosphorylated tau181 predicts cognitive and functional declineThomas F Tropea, Teresa Waligorska, Sharon X Xie, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 15, 2018
Derivation of cutoffs for the Elecsys<sup>®</sup> amyloid β (1-42) assay in Alzheimer's diseaseLeslie M Shaw, Teresa Waligorska, Leona Fields, et al.
British Journal of Anaesthesia|April 12, 2025
Associations between anaesthetic dose-adjusted intraoperative EEG alpha power, processing speed, and postoperative delirium: analysis of data from three prospective studiesMelody Reese, Mary Cooter Wright, Ken C Roberts, et al.
Annals of Clinical and Translational Neurology|February 1, 2022
Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkersMiles Berger, Jeffrey N Browndyke, Mary Cooter Wright, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 22, 2015
The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plansJu-Hee Kang, Magdalena Korecka, Michal J Figurski, et al.
Pageof 2